Access Biotechnology (life science investment arm of Access Industries)

https://www.accessindustries.com/biotechnology/

Access Biotechnology is the biopharma investment arm of Access Industries, a U.S.-based private holding company and investment firm. Access invests in private and public companies developing transformative therapies for conditions with high unmet needs across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs. *

	Start	2019-10-29 existent
	Industry	investment management
	Industry 2	LIFE SCIENCES

	City	n. a.
		Address record changed: 2024-09-01

Basic data	Employees	n. a.

		* Document for »About Section«: GRO Biosciences Inc.. (7/19/24). "Press Release: GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology". Boston, MA.

		Record changed: 2024-09-01

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Access Industries (Group)

[1] Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]